Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

TIL

Instill Bio (TIL)

Instill Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TIL
일자시간출처헤드라인심볼기업
2024/03/2206:00GlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
2024/02/1506:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2024/02/1407:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
2024/01/1821:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2024/01/1707:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2024/01/1622:00GlobeNewswire Inc.Instil Bio Announces Strategic UpdateNASDAQ:TILInstill Bio Inc
2024/01/1110:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
2024/01/1109:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
2023/12/0907:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2023/12/0607:00GlobeNewswire Inc.Instil Bio Announces Effective Date of 1-for-20 Reverse Stock SplitNASDAQ:TILInstill Bio Inc
2023/11/2721:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2023/11/1407:27Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:TILInstill Bio Inc
2023/11/1407:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
2023/11/1407:00GlobeNewswire Inc.Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
2023/11/1407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2023/11/0621:00GlobeNewswire Inc.Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual MeetingNASDAQ:TILInstill Bio Inc
2023/08/1420:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
2023/08/1420:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
2023/08/1420:00GlobeNewswire Inc.Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
2023/06/2705:38GlobeNewswire Inc.Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual ConferenceNASDAQ:TILInstill Bio Inc
2023/06/2705:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
2023/06/1505:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
2023/05/1120:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
2023/05/1120:00GlobeNewswire Inc.Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
2023/04/2905:37Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:TILInstill Bio Inc
2023/04/2505:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TILInstill Bio Inc
2023/04/1022:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TILInstill Bio Inc
2023/03/3120:40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TILInstill Bio Inc
2023/03/3120:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
2023/03/3120:00GlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
 검색 관련기사 보기:NASDAQ:TIL